Compare KPTI & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KPTI | HFFG |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.0M | 127.8M |
| IPO Year | 2013 | N/A |
| Metric | KPTI | HFFG |
|---|---|---|
| Price | $9.40 | $1.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $22.17 | N/A |
| AVG Volume (30 Days) | ★ 604.4K | 154.0K |
| Earning Date | 02-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $146,067,000.00 | ★ $1,225,541,000.00 |
| Revenue This Year | $3.55 | $4.36 |
| Revenue Next Year | N/A | $3.35 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.57 | ★ 4.10 |
| 52 Week Low | $3.51 | $1.47 |
| 52 Week High | $10.38 | $4.93 |
| Indicator | KPTI | HFFG |
|---|---|---|
| Relative Strength Index (RSI) | 71.81 | 17.81 |
| Support Level | $5.90 | $1.57 |
| Resistance Level | $9.94 | $1.75 |
| Average True Range (ATR) | 0.92 | 0.12 |
| MACD | 0.32 | -0.03 |
| Stochastic Oscillator | 87.50 | 3.95 |
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.